Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Invasion/microenvironment Apoptosis Caspases

Z-IETD-FMK, Caspase-8 inhibitor (ab141382)

Price and availability

224 476 ₸

Availability

Order now and get it on Thursday February 25, 2021

Z-IETD-FMK, Caspase-8 inhibitor (ab141382)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Caspase-8 inhibitor
  • CAS Number:
  • Purity: > 99%
  • Form / State: Lyophilized
  • Source: Synthetic

You may also be interested in

Product image
Anti-pro Caspase-9 (phospho T125) antibody (ab138412)
Product image
Recombinant human Caspase-8 protein (ab54117)
Product image
Anti-Caspase-14 antibody [EPR12927] - BSA and Azide free (ab249835)
Product image
Z-VAD(OH)-FMK, Irreversible general caspase inhibitor (ab120382)

Overview

  • Product name

    Z-IETD-FMK, Caspase-8 inhibitor
  • Description

    Caspase-8 inhibitor
  • Purity

    > 99%
  • Chemical structure

    Chemical Structure

Properties

  • Molecular weight

    654.70
  • Molecular formula

    C30H43FN4O11
  • Sequence

    IETD (Modifications: N-terminal benzyloxycarbonyl; C-terminal FMK; Glu-2 = Glu(OMe); Asp-4 = Asp(OMe))
  • PubChem identifier

    44135212
  • Storage instructions

    Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Refer to SDS for further information.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILES

    CCC(C)C(C(=O)NC(CCC(=O)OC)C(=O)NC(C(C)O)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O) OCC1=CC=CC=C1
  • Source

    Synthetic

  • Research areas

    • Cell Biology
    • Apoptosis
    • Intracellular
    • Caspases etc
    • Caspases
    • Biochemicals
    • Chemical Type
    • Biochemicals
    • Biochemicals
    • Chemical Type
    • Bioactive peptides
    • Biochemicals
    • Pharmacology
    • Enzymes
    • Caspase
    • Biochemicals
    • Pharmacology
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Heart disease
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Pain & inflammation
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Alzheimer's Disease
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Alzheimer's Disease
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Alzheimer's Disease
    • Signaling
    • Signal transduction
    • Hedgehog signaling
    • Smoothened
    • Biochemicals
    • Research Area
    • Cancer
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Diabetes
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Diabetes
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Diabetes
    • Signaling
    • Signal transduction
    • Hedgehog signaling
    • Smoothened
    • Biochemicals
    • Research Area
    • Heart disease
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Hypertension
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Hypertension
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Hypertension
    • Signaling
    • Signal transduction
    • Hedgehog signaling
    • Smoothened
    • Biochemicals
    • Research Area
    • Obesity
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Obesity
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Obesity
    • Signaling
    • Signal transduction
    • Hedgehog signaling
    • Smoothened
    • Biochemicals
    • Research Area
    • Pain & inflammation
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Respiratory disease
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Respiratory disease
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Stroke
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Stroke
    • Signaling
    • Apoptosis & cell cycle
    • Caspase
    • Biochemicals
    • Research Area
    • Stroke
    • Signaling
    • Signal transduction
    • Hedgehog signaling
    • Smoothened

Images

  • Functional Studies - Z-IETD-FMK, Caspase-8 inhibitor (ab141382)
    Functional Studies - Z-IETD-FMK, Caspase-8 inhibitor (ab141382)
    ab13847 staining active caspase 3 in SKNSH cells treated with Z-IETD-FMK (ab141382), by ICC/IF. Decrease in active caspase 3 expression correlates with increased concentration of Z-IETD-FMK, as described in literature.
    The cells were incubated at 37°C for 1 hour in media containing different concentrations of ab141382 (Z-IETD-FMK) in DMSO. After this incupation 10 µM of camptothecin (ab120115) was added to all samples and the cells were incubated for further 24 hours. The samples were then fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab13847 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DA

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Recombinant Human MSY2/YBOX2/YBX2 protein (ab162411)

  •  
  • Recombinant dog GM-CSF protein (ab200292)

  •  
  • Product image

    Recombinant rat Prolactin/PRL protein (Active) (ab269197)

  •  
  • PD 98059 (DMSO solution), MEK1 inhibitor (ab146592)

  •  
  • Sulfo-Cyanine7 azide, NIR fluorescent dye azide (ab146485)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.